Join Veristat, as well as Chief Medical Officers and R&D Executives from small to mid-sized life science companies at the Chief Medical Officer Summit East 2016 to share ideas, solutions and support for bringing new products through the clinical development process.
The conference will address the unique challenges of accomplishing this while directing and managing all R&D functions with limited resources, while raising capital and planning for the appropriate exit strategies.
Attend the Panel Discussion
Hear Veristat’s CEO Patrick Flanagan speak on the panel titled:
Whatever the Outsourcing Model, What’s the Best Way to Manage it?
Date: Wednesday, May 11, 2016
Time: 1:55 – 2:35 pm
The reality with clinical outsourcing is that it’s extremely people dependent. Once relationships are sourced and emerging biotech settles on governing and economics, the relationship moves down to different levels into the project teams. Everyone is under huge financial pressure and this tension can drive negative behavior, causing flare-ups.
In this session, we address best practices to meet the long term development needs, specifically non- traditional agreements and approaches to minimize cost, prevent change orders and ensure on time deliverability on a fixed budget. We will hear from both CROs and CMOs on what they really want from their external teams and discuss what can be different for 2016 and 2017.
- ShiYin Foo, MD, PhD Former CMO, Cardioxyl
- Catherine Wheeler, MD CMO, SVP, Clinical Development, Acetylon Pharmaceuticals
- Patrick Flanagan Chief Executive Officer,Veristat
- Lynn Sutton VP, Clinical Operations, InSeption Group, LLC
- Graham Wood, PhD EVP, Phase I Clinical Development, Altasciences Clinical Research: Vince & Associates
Schedule a Meeting
Meet with Veristat at the conference. Even if you are not attending, reach out today to schedule a meeting.